The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 300888
Securities Abbreviation: Wenkang Medical
Announcement Number: 2026-013
Announcement of Resolutions from the 11th Meeting of the 4th Board of Directors
1. Meeting Information
The 11th meeting of the 4th Board of Directors of Wenkang Medical Supplies Co., Ltd. (hereinafter referred to as "the Company") was held on April 30, 2026, in a combination of on-site and communication methods. The meeting was convened with the consent of all directors to waive the notice period. A total of 7 directors were supposed to attend, and all 7 directors were present. The meeting was chaired by Mr. Li Jianquan, the chairman, and senior management attended the meeting. The meeting complied with the relevant provisions of the Company Law and the Articles of Association.
2. Review of Meeting Resolutions
The attending directors fully discussed the proposals to be reviewed at this meeting and approved the following resolutions:
-
Approval of the Proposal on the "Three-Year Shareholder Return Plan (2026-2028)"
In response to the call for strengthening regulation to prevent risks and promote high-quality development of the capital market, and to implement the investor-centric concept, the Company has developed the "Three-Year Shareholder Return Plan (2026-2028)" to further improve its profit distribution policy and establish a sustainable, stable, and scientific shareholder return mechanism. The specific content can be found in the Company's disclosure on the same day on the Giant Tide Information Network (www.cninfo.com.cn).
Voting Results: 7 votes in favor, 0 votes against, 0 abstentions. This proposal will be submitted for shareholder meeting review. -
Approval of the Proposal on Share Repurchase for Cancellation
2.01 Purpose of Share Repurchase
Based on confidence in the Company's future development prospects and high recognition of its value, the repurchase aims to uphold the interests of the Company and its shareholders, enhance earnings per share, improve shareholder returns, convey confidence in the Company's healthy growth, and promote sustainable development while establishing a good image in the capital market.
Voting Results: 7 votes in favor, 0 votes against, 0 abstentions.